Semaglutide
2 mg per vial
Sterile lyophilized powder
Manufacturer: Hilma Biocare
€43.00
-
Worldwide Delivery
-
Payment
Description
Semaglutide 2mg
Semaglutide is a GLP-1 receptor agonist associated with the name Ozempic. Its described applications concern appetite regulation, glucose control and weight management for men and women.
Product specifications
| Property | Product information |
|---|---|
| Active substance | Semaglutide |
| Class | GLP-1 receptor agonist |
| Presentation | Lyophilized powder for reconstitution |
| Vial content | 2 mg |
| Indicative half life | Approximately 1 week |
GLP-1 signalling and satiety
Semaglutide mimics GLP-1 activity, slowing gastric emptying and reducing hunger and cravings. Its described applications include sustained weight changes through appetite and metabolic regulation, including users whose routine does not involve exercise.
- Appetite and craving reduction
- Slower gastric emptying
- Blood glucose regulation
- Sustained weight management effects
Usage and administration
The described profile includes weekly subcutaneous administration and gradual dose adjustment to limit nausea. Its numerical range of 1–3 mg per week is described in its administration context; the product content in the specifications is a separate quantity.
Related products and comparisons
Tirzepatide is discussed for dual GIP/GLP-1 activity, and Retatrutide for a three receptor metabolic profile.
Health and usage information
This page provides educational information about the product to help you make informed choices. It does not replace medical advice. If you have a health condition or questions about dosage, consult a sports medicine doctor or another healthcare professional.









Reviews
There are no reviews yet.